TrialPath
Recruiting

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

NCT07177339 · GlaxoSmithKline
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study of the Efficacy and Safety of Early Depemokimab Initiation as add-on Treatment in COPD Patients With Type 2 Inflammation
About this study
Depemokimab is being developed as a treatment for individuals with moderate to severe Chronic Obstructive Pulmonary Disorder (COPD). The aim of this study is to assess the efficacy and safety of early initiation of depemokimab as an add-on medicine in participants with moderate to severe COPD with type 2 inflammation.
Eligibility criteria
Inclusion Criteria: * Male or eligible female participants * Eosinophilic phenotype measured using Blood Eosinophil Count (BEC) * Moderate to severe COPD, defined as * A clinically documented history of COPD for at least 1 year * A post-salbutamol Forced expiratory volume in one second (FEV1)/Forced vital capacity (FVC) ratio of less than (\<)0.70 and a post-salbutamol FEV1 greater than (\>)30 percent (%) and \<80% predicted normal values * Elevated risk for exacerbations, defined as * A well-documented history of only 1 moderate COPD exacerbation in the prior 12 months and * The presence of risk factors for future exacerbations/deterioration such as: * Modified Medical Research Council (mMRC) dyspnea score \>= 2 * COPD Assessment Test (CAT) \>= 15 * Post-bronchodilator FEV1 \< 50% predicted * Chronic bronchitis * Smoking status: Current or former cigarette smokers with a history of cigarette smoking of \>=10 pack-years at Screening. * Dual (Inhaled corticosteroid (ICS)+ Long-acting beta2-adrenergic receptor agonist \[LABA\] or LABA+ Long-acting muscarinic receptor antagonist \[LAMA\]) or triple (ICS+LABA+LAMA) inhaler therapy as assessed by the investigator for at least 3 months * Body mass index (BMI) \>=16 kilograms per square meter (kg/m\^2) Exclusion Criteria: * The Investigator must judge that COPD is the primary diagnosis accounting for the clinical manifestations of lung disease, and clinical manifestations of lung disease where primary diagnosis is not COPD are excluded * Participants with a current or prior physician diagnosis of asthma * Participants with childhood asthma are permitted, provided that childhood asthma has resolved before 18 years of age and has not recurred * Other clinically significant lung disease: The Investigator must judge that COPD is the primary diagnosis accounting for the clinical manifestations of the lung disease. * COPD severity: Participants with more than one moderate exacerbation or severe exacerbation in the past 12 months prior to Visit 1 * COPD stability: Participants with pneumonia, COPD exacerbation, or lower respiratory tract infection within the 4 weeks prior to Visit 1 * Lung resection: Participants with a history of, or plan for lung volume reduction surgery/endobronchial valve procedure * Pulmonary rehabilitation: Participants in the acute phase of a pulmonary rehabilitation program within 4 weeks prior to Visit 1 * Chronic hypercapnia requiring non-invasive positive pressure ventilation (NIPPV) use including Bi-Level Positive Airway Pressure (BiPAP) or Continuous Positive Airway Pressure (CPAP) are excluded * Continuous oxygen: Participants requiring oxygen supplementation for COPD
Study design
Enrollment target: 1196 participants
Allocation: randomized
Masking: quadruple
Age groups: adult, older_adult
Timeline
Starts: 2025-10-20
Estimated completion: 2029-06-04
Last updated: 2026-11-17
Interventions
Drug: DepemokimabDrug: Placebo
Primary outcomes
  • • Annualized Rate of Moderate/Severe Exacerbations (From Baseline Up to Week 156)
Sponsor
GlaxoSmithKline · industry
Contacts & investigators
ContactUS GSK Clinical Trials Call Center · contact · GSKClinicalSupportHD@gsk.com · 877-379-3718
ContactEU GSK Clinical Trials Call Center · contact · GSKClinicalSupportHD@gsk.com · +44 (0) 20 89904466
InvestigatorGSK Clinical Trials · study_director, GlaxoSmithKline
All locations (293)
GSK Investigational SiteRecruiting
Sheffield, Alabama, United States
GSK Investigational SiteRecruiting
Tucson, Arizona, United States
GSK Investigational SiteRecruiting
Escondido, California, United States
GSK Investigational SiteRecruiting
Long Beach, California, United States
GSK Investigational SiteRecruiting
Newport Beach, California, United States
GSK Investigational SiteRecruiting
San Jose, California, United States
GSK Investigational SiteRecruiting
Lakewood, Colorado, United States
GSK Investigational SiteRecruiting
Altamonte Springs, Florida, United States
GSK Investigational SiteRecruiting
Brandon, Florida, United States
GSK Investigational SiteRecruiting
Crystal River, Florida, United States
GSK Investigational SiteRecruiting
Doral, Florida, United States
GSK Investigational SiteRecruiting
Greenacres City, Florida, United States
GSK Investigational SiteRecruiting
Hialeah, Florida, United States
GSK Investigational SiteRecruiting
Hialeah, Florida, United States
GSK Investigational SiteRecruiting
Hollywood, Florida, United States
GSK Investigational SiteRecruiting
Loxahatchee Groves, Florida, United States
GSK Investigational SiteRecruiting
Miami, Florida, United States
GSK Investigational SiteRecruiting
Miami, Florida, United States
GSK Investigational SiteRecruiting
Miami, Florida, United States
GSK Investigational SiteRecruiting
Miami, Florida, United States
GSK Investigational SiteRecruiting
Miami Lakes, Florida, United States
GSK Investigational SiteRecruiting
Miami Lakes, Florida, United States
GSK Investigational SiteRecruiting
Naples, Florida, United States
GSK Investigational SiteRecruiting
Orlando, Florida, United States
GSK Investigational SiteRecruiting
Tampa, Florida, United States
GSK Investigational SiteRecruiting
Adairsville, Georgia, United States
GSK Investigational SiteRecruiting
Cordele, Georgia, United States
GSK Investigational SiteRecruiting
Dunwoody, Georgia, United States
GSK Investigational SiteRecruiting
Boise, Idaho, United States
GSK Investigational SiteRecruiting
Peoria, Illinois, United States
GSK Investigational SiteRecruiting
Indianapolis, Indiana, United States
GSK Investigational SiteRecruiting
Bowling Green, Kentucky, United States
GSK Investigational SiteRecruiting
Baton Rouge, Louisiana, United States
GSK Investigational SiteRecruiting
Lake Charles, Louisiana, United States
GSK Investigational SiteRecruiting
Metairie, Louisiana, United States
GSK Investigational SiteRecruiting
Shreveport, Louisiana, United States
GSK Investigational SiteRecruiting
Bangor, Maine, United States
GSK Investigational SiteRecruiting
Fall River, Massachusetts, United States
GSK Investigational SiteRecruiting
Allen Park, Michigan, United States
GSK Investigational SiteRecruiting
Clarkston, Michigan, United States
GSK Investigational SiteRecruiting
Dearborn, Michigan, United States
GSK Investigational SiteRecruiting
Detroit, Michigan, United States
GSK Investigational SiteRecruiting
Missoula, Montana, United States
GSK Investigational SiteRecruiting
Henderson, Nevada, United States
GSK Investigational SiteRecruiting
Las Vegas, Nevada, United States
GSK Investigational SiteRecruiting
Reno, Nevada, United States
GSK Investigational SiteRecruiting
Sewell, New Jersey, United States
GSK Investigational SiteRecruiting
New Windsor, New York, United States
GSK Investigational SiteRecruiting
North Massapequa, New York, United States
GSK Investigational SiteRecruiting
Winston-Salem, North Carolina, United States
GSK Investigational SiteRecruiting
Winston-Salem, North Carolina, United States
GSK Investigational SiteRecruiting
Kettering, Ohio, United States
GSK Investigational SiteRecruiting
Oklahoma City, Oklahoma, United States
GSK Investigational SiteRecruiting
DuBois, Pennsylvania, United States
GSK Investigational SiteRecruiting
Philadelphia, Pennsylvania, United States
GSK Investigational SiteRecruiting
Pittsburgh, Pennsylvania, United States
GSK Investigational SiteRecruiting
Pittsburgh, Pennsylvania, United States
GSK Investigational SiteRecruiting
West Chester, Pennsylvania, United States
GSK Investigational SiteRecruiting
Greenville, South Carolina, United States
GSK Investigational SiteRecruiting
Rock Hill, South Carolina, United States
GSK Investigational SiteRecruiting
Knoxville, Tennessee, United States
GSK Investigational SiteRecruiting
Dallas, Texas, United States
GSK Investigational SiteRecruiting
DeSoto, Texas, United States
GSK Investigational SiteRecruiting
Greenville, Texas, United States
GSK Investigational SiteRecruiting
Houston, Texas, United States
GSK Investigational SiteRecruiting
Houston, Texas, United States
GSK Investigational SiteRecruiting
Houston, Texas, United States
GSK Investigational SiteRecruiting
Houston, Texas, United States
GSK Investigational SiteRecruiting
Houston, Texas, United States
GSK Investigational SiteRecruiting
Houston, Texas, United States
GSK Investigational SiteRecruiting
Katy, Texas, United States
GSK Investigational SiteRecruiting
McAllen, Texas, United States
GSK Investigational SiteRecruiting
Mesquite, Texas, United States
GSK Investigational SiteRecruiting
Pearland, Texas, United States
GSK Investigational SiteRecruiting
Stafford, Texas, United States
GSK Investigational SiteRecruiting
Lobos, Buenos Aires, Argentina
GSK Investigational SiteRecruiting
Buenos Aires, Argentina
GSK Investigational SiteRecruiting
Ciudad Autonoma de Bueno, Argentina
GSK Investigational SiteRecruiting
Córdoba, Argentina
GSK Investigational SiteRecruiting
Córdoba, Argentina
GSK Investigational SiteRecruiting
La Plata, Argentina
GSK Investigational SiteRecruiting
Mar del Plata, Argentina
GSK Investigational SiteRecruiting
Paraná, Argentina
GSK Investigational SiteRecruiting
Rosario, Argentina
GSK Investigational SiteRecruiting
Rosario Provincia de Santa FE, Argentina
GSK Investigational SiteRecruiting
San Miguel de Tucumán, Argentina
GSK Investigational SiteRecruiting
San Miguel de Tucumán, Argentina
GSK Investigational SiteRecruiting
Santa Fe, Argentina
GSK Investigational SiteRecruiting
Santa Fe, Argentina
GSK Investigational SiteRecruiting
Coffs Harbour, New South Wales, Australia
GSK Investigational SiteRecruiting
Mandurah, Western Australia, Australia
GSK Investigational SiteRecruiting
Kortrijk, Belgium
GSK Investigational SiteRecruiting
Leuven, Belgium
GSK Investigational SiteRecruiting
Mont Gaston, Belgium
GSK Investigational SiteRecruiting
Belo Horizonte, Minas Gerais, Brazil
GSK Investigational SiteRecruiting
Porto Alegre, Brazil
GSK Investigational SiteRecruiting
São Paulo, Brazil
GSK Investigational SiteRecruiting
Sofia, Grad Sofia, Bulgaria
GSK Investigational SiteRecruiting
Haskovo, Bulgaria
GSK Investigational SiteRecruiting
Montana, Bulgaria
GSK Investigational SiteRecruiting
Pleven, Bulgaria
GSK Investigational SiteRecruiting
Rousse, Bulgaria
GSK Investigational SiteRecruiting
Sofia, Bulgaria
GSK Investigational SiteRecruiting
Sofia, Bulgaria
GSK Investigational SiteRecruiting
Sofia, Bulgaria
GSK Investigational SiteRecruiting
Sofia, Bulgaria
GSK Investigational SiteRecruiting
Ajax, Ontario, Canada
GSK Investigational SiteRecruiting
Kingston, Ontario, Canada
GSK Investigational SiteRecruiting
Windsor, Ontario, Canada
GSK Investigational SiteRecruiting
Québec, Quebec, Canada
GSK Investigational SiteRecruiting
Scarborough, Canada
GSK Investigational SiteRecruiting
Temuco, Chile
GSK Investigational SiteRecruiting
Shapingba, Chongqing Municipality, China
GSK Investigational SiteRecruiting
Nanning, Guangxi, China
GSK Investigational SiteRecruiting
Haikou, Hainan, China
GSK Investigational SiteRecruiting
Chengdu, Sichuan, China
GSK Investigational SiteRecruiting
Chengdu, Sichuan, China
GSK Investigational SiteRecruiting
Suining, Sichuan, China
GSK Investigational SiteRecruiting
Beijing, China
GSK Investigational SiteRecruiting
Beijing, China
GSK Investigational SiteRecruiting
Changchun, China
GSK Investigational SiteRecruiting
Changchun, China
GSK Investigational SiteRecruiting
Changsha, China
GSK Investigational SiteRecruiting
Chengdu, China
GSK Investigational SiteRecruiting
Chongqing, China
GSK Investigational SiteRecruiting
Dongguan, China
GSK Investigational SiteRecruiting
Fujian, China
GSK Investigational SiteRecruiting
Guangzhou, China
GSK Investigational SiteRecruiting
Guangzhou, China
GSK Investigational SiteRecruiting
Guangzhou, China
GSK Investigational SiteRecruiting
Guilin, China
GSK Investigational SiteRecruiting
Haikou, China
GSK Investigational SiteRecruiting
Hangzhou, China
GSK Investigational SiteRecruiting
Harbin, China
GSK Investigational SiteRecruiting
Hefei, China
GSK Investigational SiteRecruiting
Hohhot, China
GSK Investigational SiteRecruiting
Hohhot, China
GSK Investigational SiteRecruiting
Huizhou, China
GSK Investigational SiteRecruiting
Jiangmen, China
GSK Investigational SiteRecruiting
Jiangmen, China
GSK Investigational SiteRecruiting
Jinzhou, China
GSK Investigational SiteRecruiting
Nanchang, China
GSK Investigational SiteRecruiting
Nanchang, China
GSK Investigational SiteRecruiting
Nanjing, China
GSK Investigational SiteRecruiting
Qinhuangdao, China
GSK Investigational SiteRecruiting
Shanghai, China
GSK Investigational SiteRecruiting
Shanghai, China
GSK Investigational SiteRecruiting
Shijiazhuang, China
GSK Investigational SiteRecruiting
Shijiazhuang, China
GSK Investigational SiteRecruiting
Taiyuan, China
GSK Investigational SiteRecruiting
Taizhou, China
GSK Investigational SiteRecruiting
Taizhou, China
GSK Investigational SiteRecruiting
Ürümqi, China
GSK Investigational SiteRecruiting
Weifang, China
GSK Investigational SiteRecruiting
Wenzhou, China
GSK Investigational SiteRecruiting
Xiamen, China
GSK Investigational SiteRecruiting
Xinxiang, China
GSK Investigational SiteRecruiting
Yinchuan, China
GSK Investigational SiteRecruiting
Zunyi, China
GSK Investigational SiteRecruiting
Aalborg, Denmark
GSK Investigational SiteRecruiting
Hvidovre, Denmark
GSK Investigational SiteRecruiting
Roskilde, Denmark
GSK Investigational SiteRecruiting
Vejle, Denmark
GSK Investigational SiteRecruiting
Aix-en-Provence, France
GSK Investigational SiteRecruiting
Amiens, France
GSK Investigational SiteRecruiting
Caen, France
GSK Investigational SiteRecruiting
La Tronche, France
GSK Investigational SiteRecruiting
Montivilliers, France
GSK Investigational SiteRecruiting
Nîmes, France
GSK Investigational SiteRecruiting
Vandœuvre-lès-Nancy, France
GSK Investigational SiteRecruiting
Heidelberg, Baden-Wurttemberg, Germany
GSK Investigational SiteRecruiting
Löwenstein, Baden-Wurttemberg, Germany
GSK Investigational SiteRecruiting
Frankfurt am Main, Hesse, Germany
GSK Investigational SiteRecruiting
Essen, North Rhine-Westphalia, Germany
GSK Investigational SiteRecruiting
Bendorf, Rhineland-Palatinate, Germany
GSK Investigational SiteWithdrawn
Ahrensburg, Germany
GSK Investigational SiteRecruiting
Berlin, Germany
GSK Investigational SiteRecruiting
Berlin, Germany
GSK Investigational SiteRecruiting
Berlin, Germany
GSK Investigational SiteWithdrawn
Berlin, Germany
GSK Investigational SiteRecruiting
Bonn, Germany
GSK Investigational SiteRecruiting
Frankfurt, Germany
GSK Investigational SiteRecruiting
Hamburg, Germany
GSK Investigational SiteRecruiting
Leipzig, Germany
GSK Investigational SiteRecruiting
Leipzig, Germany
GSK Investigational SiteRecruiting
Mainz, Germany
GSK Investigational SiteRecruiting
Marburg, Germany
GSK Investigational SiteRecruiting
München, Germany
GSK Investigational SiteRecruiting
München, Germany
GSK Investigational SiteRecruiting
Wuppertal, Germany
GSK Investigational SiteRecruiting
Palaió Fáliro, Anatoliki Attiki, Greece
GSK Investigational SiteRecruiting
Marousi, Attica, Greece
GSK Investigational SiteRecruiting
Thessaloniki, Central Macedonia, Greece
GSK Investigational SiteRecruiting
Athens, Greece
GSK Investigational SiteRecruiting
Ioannina, Greece
GSK Investigational SiteRecruiting
Thessaloniki, Greece
GSK Investigational SiteRecruiting
Mosonmagyaróvár, Hungary
GSK Investigational SiteRecruiting
Pécs, Hungary
GSK Investigational SiteRecruiting
Ashdod, Israel
GSK Investigational SiteRecruiting
Haifa, Israel
GSK Investigational SiteRecruiting
Jerusalem, Israel
GSK Investigational SiteRecruiting
Kfar Saba, Israel
GSK Investigational SiteRecruiting
Petah Tikva, Israel
GSK Investigational SiteRecruiting
Ramat Gan, Israel
GSK Investigational SiteRecruiting
Tel Aviv, Israel
GSK Investigational SiteRecruiting
Tiberias, Israel
GSK Investigational SiteRecruiting
Brescia, BS, Italy
GSK Investigational SiteRecruiting
Ferrara, Italy
GSK Investigational SiteRecruiting
Roma, Italy
GSK Investigational SiteRecruiting
Chiba, Japan
GSK Investigational SiteRecruiting
Fukuoka, Japan
GSK Investigational SiteRecruiting
Fukuoka, Japan
GSK Investigational SiteRecruiting
Fukuoka, Japan
GSK Investigational SiteRecruiting
Fukushima, Japan
GSK Investigational SiteRecruiting
Gifu, Japan
GSK Investigational SiteRecruiting
Hiroshima, Japan
GSK Investigational SiteRecruiting
Hokkaido, Japan
GSK Investigational SiteRecruiting
Hyōgo, Japan
GSK Investigational SiteRecruiting
Hyōgo, Japan
GSK Investigational SiteRecruiting
Hyōgo, Japan
GSK Investigational SiteRecruiting
Ishikawa, Japan
GSK Investigational SiteRecruiting
Kagawa, Japan
GSK Investigational SiteRecruiting
Kanagawa, Japan
GSK Investigational SiteRecruiting
Kitakyushu, Japan
GSK Investigational SiteRecruiting
Kyoto, Japan
GSK Investigational SiteRecruiting
Mie, Japan
GSK Investigational SiteRecruiting
Miyagi, Japan
GSK Investigational SiteRecruiting
Miyazaki, Japan
GSK Investigational SiteRecruiting
Nankoku-shi, Japan
GSK Investigational SiteRecruiting
Niigata, Japan
GSK Investigational SiteRecruiting
Niigata, Japan
GSK Investigational SiteRecruiting
Osaka, Japan
GSK Investigational SiteRecruiting
Osaka, Japan
GSK Investigational SiteRecruiting
Osaka, Japan
GSK Investigational SiteRecruiting
Osaka, Japan
GSK Investigational SiteRecruiting
Osaka, Japan
GSK Investigational SiteRecruiting
Shizuoka, Japan
GSK Investigational SiteRecruiting
Shizuoka, Japan
GSK Investigational SiteRecruiting
Shizuoka, Japan
GSK Investigational SiteRecruiting
Shizuoka, Japan
GSK Investigational SiteRecruiting
Tokyo, Japan
GSK Investigational SiteRecruiting
Tokyo, Japan
GSK Investigational SiteRecruiting
Tokyo, Japan
GSK Investigational SiteRecruiting
Yamaguchi, Japan
GSK Investigational SiteRecruiting
Yokohama, Japan
GSK Investigational SiteRecruiting
Breda, North Brabant, Netherlands
GSK Investigational SiteRecruiting
Enschede, Netherlands
GSK Investigational SiteRecruiting
Ebdentown, Upper Hutt, New Zealand
GSK Investigational SiteRecruiting
Hamilton, New Zealand
GSK Investigational SiteRecruiting
Rotorua, New Zealand
GSK Investigational SiteRecruiting
Poznan, Greater Poland Voivodeship, Poland
GSK Investigational SiteRecruiting
Bialystok, Poland
GSK Investigational SiteRecruiting
Poznan, Poland
GSK Investigational SiteRecruiting
Rzeszów, Poland
GSK Investigational SiteRecruiting
Sosnowiec, Poland
GSK Investigational SiteRecruiting
Skotniki, Łódź Voivodeship, Poland
GSK Investigational SiteRecruiting
Timișoara, Timiș County, Romania
GSK Investigational SiteRecruiting
Timișoara, Timiș County, Romania
GSK Investigational SiteRecruiting
Bucharest, Romania
GSK Investigational SiteRecruiting
Seoul, Seoul Teugbyeolsi, South Korea
GSK Investigational SiteRecruiting
Seoul, Seoul Teugbyeolsi, South Korea
GSK Investigational SiteRecruiting
Daegu, South Korea
GSK Investigational SiteRecruiting
Incheon, South Korea
GSK Investigational SiteRecruiting
Jeonju, South Korea
GSK Investigational SiteRecruiting
Seongnam-si Gyeonggi-do, South Korea
GSK Investigational SiteRecruiting
Seoul, South Korea
GSK Investigational SiteRecruiting
Seoul, South Korea
GSK Investigational SiteRecruiting
Alzira, Spain
GSK Investigational SiteRecruiting
Barcelona, Spain
GSK Investigational SiteRecruiting
Benalmádena, Spain
GSK Investigational SiteRecruiting
Lleida, Spain
GSK Investigational SiteRecruiting
Madrid, Spain
GSK Investigational SiteRecruiting
Madrid, Spain
GSK Investigational SiteRecruiting
Málaga, Spain
GSK Investigational SiteRecruiting
Málaga, Spain
GSK Investigational SiteRecruiting
Palma de Mallorca, Spain
GSK Investigational SiteRecruiting
Pontevedra, Spain
GSK Investigational SiteRecruiting
Valladolid, Spain
GSK Investigational SiteRecruiting
Kaohsiung City, Taiwan
GSK Investigational SiteRecruiting
Taichung, Taiwan
GSK Investigational SiteRecruiting
Taipei, Taiwan
GSK Investigational SiteRecruiting
Truro, Cornwall, United Kingdom
GSK Investigational SiteRecruiting
Uxbridge, Middlesex, United Kingdom
GSK Investigational SiteRecruiting
Bedford, United Kingdom
GSK Investigational SiteRecruiting
Birmingham, United Kingdom
GSK Investigational SiteRecruiting
Bradford, United Kingdom
GSK Investigational SiteRecruiting
Corby, United Kingdom
GSK Investigational SiteRecruiting
Dagenham, United Kingdom
GSK Investigational SiteRecruiting
Leicester, United Kingdom
GSK Investigational SiteRecruiting
London, United Kingdom
GSK Investigational SiteRecruiting
London, United Kingdom
GSK Investigational SiteRecruiting
London, United Kingdom
GSK Investigational SiteRecruiting
Sheffield, United Kingdom
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation · TrialPath